Skandinaviska Enskilda Banken (SEB)’s Iovance Biotherapeutics IOVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-155,684	Closed	-$518K	–	865
2025 Q1	$518K	Hold	155,684	–	–	﹤0.01%	686
2024 Q4	$1.11M	Buy	155,684 +41,732	+37%	+$387K	0.01%	647
2024 Q3	$1.07M	Hold	113,952	–	–	﹤0.01%	662
2024 Q2	$912K	Hold	113,952	–	–	﹤0.01%	649
2024 Q1	$1.69M	Buy	113,952 +17,334	+18%	+$202K	0.01%	606
2023 Q4	$785K	Hold	96,618	–	–	﹤0.01%	725
2023 Q3	$440K	Hold	96,618	–	–	﹤0.01%	778
2023 Q2	$680K	Hold	96,618	–	–	﹤0.01%	752
2023 Q1	$590K	Sell	96,618 -4,756	-5%	-$32.8K	﹤0.01%	756
2022 Q4	$648K	Sell	101,374 -5,875	-5%	-$45.9K	﹤0.01%	710
2022 Q3	$1.03M	Buy	107,249 +60,039	+127%	+$692K	0.01%	676
2022 Q2	$521K	Hold	47,210	–	–	﹤0.01%	801
2022 Q1	$786K	Hold	47,210	–	–	﹤0.01%	784
2021 Q4	$917K	Hold	47,210	–	–	﹤0.01%	781
2021 Q3	$1.16M	Buy	47,210 +24,544	+108%	+$578K	0.01%	762
2021 Q2	$590K	Hold	22,666	–	–	﹤0.01%	863
2021 Q1	$718K	Buy	+22,666	New	+$940K	﹤0.01%	881